13D Filings
DallasNews Corp
Amendment
Ownership

9.90%

Total Shares

470,000

Issuer CIK

1413898

CUSIP

235050101

Event Date

Aug 18, 2025

Accepted

Aug 19, 2025, 08:08 AM

Reporting Persons (5)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
Strategic Investment Opportunities LLC
Other
9.90%470,0000470,000
MNG Enterprises, Inc.
CO
9.90%470,0000470,000
MNG Investment Holdings LLC
Other
9.90%470,0000470,000
Freeman Heath
Individual
9.90%470,0000470,000
Alden Global Capital LLC
Investment Adviser
9.90%470,0000470,000
Disclosure Items (4)

Security Title

Series A Common Stock, $0.01 par value

Issuer Name

DallasNews Corp

Issuer Address

P.O. Box 224866, Dallas, TX, 75222-4866

Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On August 19, 2025, MNG delivered a letter to the Board (the "Further Enhanced Proposal Letter") setting forth the terms of its further enhanced offer (the "Further Enhanced Proposal") to acquire all of the issued and outstanding shares of the Issuer's Common Stock not already owned by MNG for $18.50 per share in cash, which represents a $2.00 per share increase over its initial Proposal of $16.50 per share and a $1.00 per share increase over its Enhanced Proposal of $17.50 per share. The foregoing description of the Further Enhanced Proposal Letter is qualified in its entirety by reference to the full text of the Further Enhanced Proposal Letter, a copy of which is included as Exhibit 99.7 to this Schedule 13D and is incorporated by reference in its entirety.

Item 5(a) of the Schedule 13D is hereby amended and supplemented as follows: As of the date hereof, the Reporting Persons may be deemed to beneficially own 470,000 shares of Series A Common Stock, or approximately 9.9% of the Series A Common Stock outstanding. The percentage of Series A Common Stock reported as beneficially owned by the Reporting Persons is based on 4,739,025 shares of Series A Common Stock outstanding as of August 14, 2025, as reported in the definitive proxy statement on Schedule 14A filed by the Issuer on August 15, 2025.

Item 7 of the Schedule 13D is hereby amended and supplemented as follows: Exhibit Description Exhibit 99.7: Further Enhanced Proposal Letter to the Board, dated August 19, 2025